BACKGROUND AND OBJECTIVE: The aims of this study were to describe the process of implementation of the PISCIS cohort, and to describe the clinical and epidemiological characteristics and trends of antiretroviral treatment (ART) among patients enrolled from 1998 through 2003. PATIENTS AND METHOD: Prospective cohort study of HIV-infected patients aged > or = 16 years newly attended in 10 Catalonian hospitals and one Balearic Islands hospital. Analysis were done using the Mantel's chi2 test for trend. RESULTS: A total of 5,968 patients (mean age 39 yrs; 75% men) were recruited with a mean follow-up of 26.4 months (13,130 person-years). A total of 2,763 patients were newly diagnosed and among these, the most frequent transmission route was the heterosexual one (43%), followed by homosexual (31%). We observed an increasing trend in the proportion of persons < 35 years and immigrants. Among newly diagnosed, 43% had < 200 CD4 T cells/microl in the nearest determination from HIV diagnosis. In the year 2003, 83% of patients were on ART. A decrease of the protease inhibitor-based regimen (from 85% in 1998 to 25% in 2003; p < 0.001) and an increase of nucleoside and non-nucleoside analogue reverse transcriptase inhibitors-containing regimens were observed over time among naive patients who started ART with three or more drugs. CONCLUSIONS: HIV infected patients' cohorts are feasible in our setting and are an important tool in clinical and public health. The heterosexual route of transmission was the most frequent among newly diagnosed patients. The diagnosis delay is high and, on the other hand, ARV regimens have been changing according to the recommended guidelines.
BACKGROUND AND OBJECTIVE: The aims of this study were to describe the process of implementation of the PISCIS cohort, and to describe the clinical and epidemiological characteristics and trends of antiretroviral treatment (ART) among patients enrolled from 1998 through 2003. PATIENTS AND METHOD: Prospective cohort study of HIV-infectedpatients aged > or = 16 years newly attended in 10 Catalonian hospitals and one Balearic Islands hospital. Analysis were done using the Mantel's chi2 test for trend. RESULTS: A total of 5,968 patients (mean age 39 yrs; 75% men) were recruited with a mean follow-up of 26.4 months (13,130 person-years). A total of 2,763 patients were newly diagnosed and among these, the most frequent transmission route was the heterosexual one (43%), followed by homosexual (31%). We observed an increasing trend in the proportion of persons < 35 years and immigrants. Among newly diagnosed, 43% had < 200 CD4 T cells/microl in the nearest determination from HIV diagnosis. In the year 2003, 83% of patients were on ART. A decrease of the protease inhibitor-based regimen (from 85% in 1998 to 25% in 2003; p < 0.001) and an increase of nucleoside and non-nucleoside analogue reverse transcriptase inhibitors-containing regimens were observed over time among naive patients who started ART with three or more drugs. CONCLUSIONS:HIV infectedpatients' cohorts are feasible in our setting and are an important tool in clinical and public health. The heterosexual route of transmission was the most frequent among newly diagnosed patients. The diagnosis delay is high and, on the other hand, ARV regimens have been changing according to the recommended guidelines.
Authors: Margaret T May; Robert S Hogg; Amy C Justice; Bryan E Shepherd; Dominique Costagliola; Bruno Ledergerber; Rodolphe Thiébaut; M John Gill; Ole Kirk; Ard van Sighem; Michael S Saag; Gemma Navarro; Paz Sobrino-Vegas; Fiona Lampe; Suzanne Ingle; Jodie L Guest; Heidi M Crane; Antonella D'Arminio Monforte; Jörg J Vehreschild; Jonathan A C Sterne Journal: Int J Epidemiol Date: 2012-11-12 Impact factor: 7.196
Authors: Marcel Zwahlen; Ross Harris; Margaret May; Robert Hogg; Dominique Costagliola; Frank de Wolf; John Gill; Gerd Fätkenheuer; Charlotte Lewden; Mike Saag; Sholmo Staszewski; Antonella d'Arminio Monforte; Jordi Casabona; Fiona Lampe; Amy Justice; Viktor von Wyl; Matthias Egger Journal: Int J Epidemiol Date: 2009-10-09 Impact factor: 7.196
Authors: Michael J Mugavero; Margaret May; Ross Harris; Michael S Saag; Dominique Costagliola; Matthias Egger; Andrew Phillips; Huldrych F Günthard; Francois Dabis; Robert Hogg; Frank de Wolf; Gerd Fatkenheuer; M John Gill; Amy Justice; Antonella D'Arminio Monforte; Fiona Lampe; Jose M Miró; Schlomo Staszewski; Jonathan A C Sterne Journal: AIDS Date: 2008-11-30 Impact factor: 4.177
Authors: J Reyes-Urueña; C Campbell; C Hernando; N Vives; C Folch; L Ferrer; L Fernández-López; A Esteve; J Casabona Journal: Epidemiol Infect Date: 2017-03-08 Impact factor: 4.434
Authors: Paz Sobrino-Vegas; Santiago Pérez-Hoyos; Ronald Geskus; Belén Padilla; Ferrán Segura; Rafael Rubio; Jorge Del Romero; Jesus Santos; Santiago Moreno; Julia Del Amo Journal: AIDS Res Treat Date: 2011-10-15
Authors: Juliana Maria Reyes-Urueña; Colin N J Campbell; Núria Vives; Anna Esteve; Juan Ambrosioni; Cristina Tural; Elena Ferrer; Gemma Navarro; Lluis Force; Isabel García; Àngels Masabeu; Josep M Vilaró; Patricia García de Olalla; Joan Artur Caylà; Josep M Miró; Jordi Casabona Journal: BMJ Open Date: 2018-02-28 Impact factor: 2.692
Authors: Valeria Stuardo; Cristina Agustí; José Manuel Godinez; Alexandra Montoliu; Aureli Torné; Antoni Tarrats; Carmen Alcalde; Dolores Martín; Eulalia Fernández-Montoli; Cristina Vanrell; Josefa Solé; Yolanda Canet; José Manuel Marqueta; Jadiyettu Mohamed; Isabel Cuenca; Montserrat Lonca; Guillem Sirera; Elena Ferrer; Pere Domingo; Belen Lloveras; Josep María Miro; Silvia De Sanjosé; Jordi Casabona Journal: PLoS One Date: 2012-10-30 Impact factor: 3.240
Authors: Jonathan A C Sterne; Margaret May; Dominique Costagliola; Frank de Wolf; Andrew N Phillips; Ross Harris; Michele Jönsson Funk; Ronald B Geskus; John Gill; François Dabis; Jose M Miró; Amy C Justice; Bruno Ledergerber; Gerd Fätkenheuer; Robert S Hogg; Antonella D'Arminio Monforte; Michael Saag; Colette Smith; Schlomo Staszewski; Matthias Egger; Stephen R Cole Journal: Lancet Date: 2009-04-08 Impact factor: 79.321